SkylineDx has published a new study marking a “significant advancement” in understanding and identifying high-risk multiple ...
Pulnovo Medical has closed a Series C financing round, securing around $100m for progressing the company's worldwide trials.
UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback